Pharmacoeconomics: NICE's approach to decision-making

British Journal of Clinical Pharmacology

Volumn 70, Issue 3, 2010, Pages 346-349

  Rawlins, Michael ^a   Barnett, David ^a,b   Stevens, Andrew ^a,c  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; IMATINIB; INSULIN; LENALIDOMIDE; OMALIZUMAB; PEMETREXED; RANIBIZUMAB; RILUZOLE; SUNITINIB; TRASTUZUMAB;

ADRENAL CANCER; ASTHMA; BREAST CANCER; CHRONIC MYELOID LEUKEMIA; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISEASE SEVERITY; GASTROINTESTINAL STROMAL TUMOR; GROWTH HORMONE DEFICIENCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; JUSTICE; MALIGNANT MESOTHELIOMA; MEDICAL TECHNOLOGY; MOTOR NEURON DISEASE; MULTIPLE MYELOMA; NATIONAL HEALTH SERVICE; PHARMACOECONOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; SOCIAL PSYCHOLOGY; TERMINAL CARE; UNITED KINGDOM;

DECISION MAKING; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; GOVERNMENT AGENCIES; GREAT BRITAIN; HUMANS; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; STATE MEDICINE;

EID: 77955743587     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03589.x     Document Type: Short Survey

References (10)

1. Secretary of State for Health. Directions to Primary Care Trusts and NHS trusts in England concerning Arrangements for the Funding of Technology Appraisal Guidance from the National Institute for Clinical Excellence (NICE). London : Department of Health, 2003.
2. National Institute for Health and Clinical Excellence. Developing NICE Technology Appraisal Guidance. London & Manchester : National Institute for Health and Clinical Excellence, 2008. Available at http://www.nice.org.uk/ aboutnice/howwework/devnicetech/developing-nice-technology-appraisals.jsp.
3. National Institute for Health and Clinical Excellence. Developing NICE Clinical Guidelines. London & Manchester : National Institute for Health and Clinical Excellence, 2008. Available at http://www.nice.org.uk/aboutnice/ howwework/developingniceclinicalguidelines/developing-nice-clinical-guidelines. jsp.
4. National Institute for Health and Clinical Excellence. Developing NICE Public Health Guidance. London & Manchester : National Institute for Health and Clinical Excellence, 2008. Available at http://www.nice.org.uk/aboutnice/ howwework/developingnicepublichealthguidance/developing-nice-public-health- guidance.jsp.
5. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgements. BMJ 2004 329 : 224 227.
6. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London : National Institute for Health and Clinical Excellence, 2008.
7. Rawlins MD. De Testimonio. On the Evidence for Decisions about the Use of Therapeutic Interventions. London : Royal College of Physicians, 2008.
8. Sutton A, Ades A, Abrams K, Cooper N. Briefing Paper for Methods Review Workshop on Evidence Synthesis (Indirect and Mixed Treatment Comparisons). London : National Institute for Health and Clinical Excellence, 2008. Available at http://www.nice.org.uk/media/4A6/2F/EvidenceSynthesisBriefingPaper.pdf.
9. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Oxford and New York : Oxford University Press, 2001.
10. National Institute for Health and Clinical Excellence. Social Value Judgements: Principles for the Development of NICE's Guidance. London : National Institute for Health and Clinical Excellence, 2005.